NewsOK member benefits
Web Search powered by YAHOO!
Published: February 15, 2008
OMRF, drug company settle patent lawsuit
Somewhere along the road from drug discovery to commercialization, the relationship fell part between Oklahoma Medical Research Foundation and the company that licensed its intellectual property to create the drug Soliris .
As approval of the drug by federal regulators neared in 2006, Connecticut -based Alexion Pharmaceuticals declared that the intellectual property licensed from OMRF didn't apply to Soliris.
You have selected to view an article that is older than 60 days. Get access to all our historical content by purchasing a pass to The Oklahoman. Select the option that works best for you.
Archive Subscription types & rates
